Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2/3 1Phase 2 1

Status

Completed 5Recruiting 3Unknown 1Terminated 1Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 1

Conditions

Skin Neoplasms 1Depression 1Anxiety Disorders 1Advanced Cancer 1

Interventions

pembrolizumab 555Specimen Handling 459Carboplatin 446Magnetic Resonance Spectroscopy 427Cyclophosphamide 412Cisplatin 404Gemcitabine 314Radiotherapy 313Bevacizumab 310Paclitaxel 300Biopsy 260Drug Therapy 252Capecitabine 241Oxaliplatin 240fludarabine 236Nivolumab 226venetoclax 225Injections 214Docetaxel 203Fluorouracil 201Dexamethasone 186Radiosurgery 172Rituximab 161Pemetrexed 157durvalumab 144Standard of Care 143atezolizumab 139toripalimab 137tislelizumab 137Leucovorin 137

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Interventional × Niacin × Clear all
NCT06200155 2026-04-16

Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

M.D. Anderson Cancer Center

Phase 2 Recruiting
30 enrolled

Anxiety Disorders, Depression

NCT05702398 2026-03-20

Pilot Trial of Supplemental Vitamin A and Nicotinamide

Rhode Island Hospital

Phase EARLY_PHASE1 Recruiting
30 enrolled
Dermatologic

Skin Neoplasms

NCT05398484 2025-12-04

Psilocybin Therapy in Advanced Cancer

NYU Langone Health

Phase 2/3 Recruiting
200 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡